作为阿尔茨海默病的多目标导向配体的基基基衍生物DK02:一项在斑马鱼中进行的临床前研究

Balasubramanian Haridevamuthu1, Ankit Kumar Bharti1, Santosh Pushpa Ramya Ranjan Nayak1

  • 1Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.

PubMed
概括

DK02是一种新型化合物,通过改善认知功能和减少神经退行,对阿尔茨海默病 (AD) 具有前景. 这种多目标疗法针对关键的AD途径,为当前的症状治疗提供了潜在的替代方案.